l e t t e r s Gli2 tg mice, in which the bovine KRT5 promoter drives constitutive expression of mouse Gli2 (ref. 6), develop BCC and basaloid follicular hamartoma (BFH) 6,7 , which are both linked to deregulated Hh signaling in humans 7, 8 . Gli2 tg mice show a reproducible pattern of lesions on the ear that successively involves hyperkeratosis (flaking), thickening and hyperpigmentation ( Supplementary Fig. 1a ). We scored mice as positive for the onset of lesions upon the first sign of macroscopic hyperkeratosis in ear tissue. Histologically, the lesions present between postnatal day (P) 80 and P120 resembled BFH as previously described 7, 8 . By P180, larger, nodular, BCC-like tumors frequently occured deeper in the dermis (Supplementary Fig. 1a) . Male Gli2 tg mice consistently developed lesions earlier than females (Supplementary Fig. 1b) . Induction of Krt17, a gene targeted by Gli 9 , is the main alteration in keratin expression before onset of lesions in the epidermis of Gli2 tg mice (Supplementary Fig. 1c) .
Gli2 tg mice, in which the bovine KRT5 promoter drives constitutive expression of mouse Gli2 (ref. 6) , develop BCC and basaloid follicular hamartoma (BFH) 6, 7 , which are both linked to deregulated Hh signaling in humans 7, 8 . Gli2 tg mice show a reproducible pattern of lesions on the ear that successively involves hyperkeratosis (flaking), thickening and hyperpigmentation (Supplementary Fig. 1a ). We scored mice as positive for the onset of lesions upon the first sign of macroscopic hyperkeratosis in ear tissue. Histologically, the lesions present between postnatal day (P) 80 and P120 resembled BFH as previously described 7, 8 . By P180, larger, nodular, BCC-like tumors frequently occured deeper in the dermis (Supplementary Fig. 1a ). Male Gli2 tg mice consistently developed lesions earlier than females (Supplementary Fig. 1b) . Induction of Krt17, a gene targeted by Gli 9 , is the main alteration in keratin expression before onset of lesions in the epidermis of Gli2 tg mice (Supplementary Fig. 1c) .
We interbred Gli2 tg and Krt17 −/− mice 6, 10 to assess the impact of Krt17 loss on the genesis of BFH-like tumors. We monitored the appearance and progression of hamartoma-like lesions from P30 to P125. At P80, epithelial lesions were clearly less pronounced in ear tissue from Gli2 tg ; Krt17 −/− mice than in ear tissue from Gli2 tg mice (Fig. 1a , male data shown). In male Gli2 tg and Gli2 tg ; Krt17 −/− mice, the average onset of lesions ± s.e.m. was 65 days ± 2 days (n = 32) and 91 days ± 2 days (n = 31, P < 0.01), respectively. In females, the average onset of lesions was at 80 days ± 5 days for Gli2 tg mice (n = 22) compared to 101 days ± 2 days in Gli2 tg ; Krt17 −/− mice (n = 21, P < 0.01; Fig. 1b and Supplementary Fig. 2a ). Gli2 tg mice lacking Krt14 (ref. 11) did not display such a delay (Fig. 1c) , establishing the specificity of the impact of Krt17 loss. Gli2 transgene expression was similar in both Gli2 tg and Gli2 tg ; Krt17 −/− mice (Fig. 1d) . Loss of Krt17 did not alter Gli2 subcellular localization or Hh signaling ( Supplementary  Fig. 2b-d) . Therefore, we conclude that the absence of Krt17 causes a delay in the inception of BFH-like skin tumors in Gli2 tg mice.
Next, we scored histological anomalies common to Hh pathwayactivated mouse skin 7 in Gli2 tg and Gli2 tg ; Krt17 −/− ear tissue (Supplementary Fig. 3a) . Such anomalies, absent in wild-type and Krt17 −/− mouse ears (Supplementary Fig. 3b ), were prominent in Gli2 tg ears but were markedly reduced in Gli2 tg ; Krt17 −/− ears ( Supplementary Fig. 3c ). Overall tissue thickness and penetration of epithelial downgrowths were also reduced in Gli2 tg ; Krt17 −/− ear tissue ( Supplementary Fig. 3d,e) . Krt17, Krt5 and Krt14 were uniformly distributed in the lesional epithelium (Supplementary Fig. 3f ). Coassembly of Krt5 and Krt17 in Gli2 tg lesional epithelium is suggested by their co-localization and coimmunoprecipitation ( Supplementary  Fig. 3g,h) . The wound-inducible proteins Krt6α, Krt6β and Krt16, absent in intact epidermis, were induced preferentially in the upper layers of thickened Gli2 tg epidermis but were markedly reduced in Gli2 tg ; Krt17 −/− skin ( Supplementary Fig. 3f,i) .
Reduced cell proliferation, rather than increased cell death, is a key contributor in the delay of tumor onset in Gli2 tg ; Krt17 −/− skin. Indeed, relative to Gli2 tg , the frequency of mitotically active cells was reduced more than 3-fold in Gli2 tg ; Krt17 −/− ear epithelium ( Fig. 1e-g ). In contrast, Tunel-positive apoptotic cells were restricted to the upper epidermis of lesional skin and showed similar density in both genotypes (Fig. 1h) .
Inflammation has emerged as a driver of angiogenesis and tumor growth 12 and it coincides with Krt17 induction and loss-of-barrier function in several skin diseases 13, 14 . Immunoreactivity for markers of innate immune cells (CD11b), T cells (Thy-1) and phagocytes (iNOS) were enhanced in Gli2 tg ear skin compared to Gli2 tg ; Krt17 −/− ear skin of P80 male mice (Fig. 2a) . PECAM antibody staining was also decreased in Gli2 tg ; Krt17 −/− ear skin (Fig. 2a) , reflecting decreased angiogenesis. Myeloperoxidase (MPO) enzymatic activity, inherent to neutrophils 15 , was increased 17.4-fold ± 0.5-fold (s.e.m.) in P80 male Gli2 tg ear tissue but was only increased 5.8-fold ± 0.1-fold in Gli2 tg ; Krt17 −/− P80 males (this data was normalized to P80 female Gli2 tg ear tissue; 
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VOLUME 42 | NUMBER 10 | OCTOBER 2010 Nature GeNetics l e t t e r s seen in Gli2 tg controls (Fig. 2b) . Skin barrier integrity in P80 male Gli2 tg ; Krt17 −/− mice, assessed by a whole-mount dye penetration assay 16 , was intact as would be expected in P70 wild-type ear skin (Fig. 2c) . In contrast, a sizable portion of the ear was dye-permeable in P70 Gli2 tg mice (Fig. 2c) ; this readout was markedly decreased in Gli2 tg ; Krt17 −/− mice (Fig. 2c) . At P40, that is, before onset of histological anomalies (Fig. 2d) , MPO activity was 5.9-fold ± 1.9-fold greater in male Gli2 tg mice relative to female Gli2 tg mice, substantiating the gender bias in this model. MPO activity was lower in P40 male Gli2 tg ; Krt17 −/− mice (0.55-fold ± 0.20-fold) relative to female Gli2 tg mice (Fig. 2e) . Although epidermal thickness was the same (Fig. 2d) , mitotic activity was higher in Gli2 tg epidermis compared to Gli2 tg ; Krt17 −/− epidermis at P40 (0.52 ± 0.01 compared to 0.14 ± 0.02 bromodeoxyuridine-labeled cells per millimeter of epidermis, respectively) (Fig. 2f) , and the Gli2 tg skin tissue was infiltrated with various types of leukocytes. Barrier integrity was mildly compromised in P40 Gli2 tg ear skin and was better preserved in Gli2 tg ; Krt17 −/− mice (Supplementary Fig. 4a) . Thus, the marked reductions in inflammation and hyperplasia that define Gli2 tg ; Krt17 −/− ear skin occur as early as P40, before progression to overt tumorigenesis in the Gli2 tg model.
We examined expression of inflammatory cytokines and chemokines via quantative RT-PCR in ear tissue at P40 and P80. We stratified the findings according to specific classes of T-helper cytokines: Th1 (cellular immunity, generally 'pro-inflammatory'), Th2 (humoral immunity, 'anti-inflammatory') and Th17 (antimicrobial immunity at epithelial barriers) 17, 18 . Th1 and Th17 hyperactivity occur in psoriasis 19 . Absence of Krt17 in Gli2 tg skin correlated with a marked reduction in Th1-and Th17-related markers and induction of Th2-related markers ( Table 1) , many of which are prominently expressed by skin keratinocytes themselves. Expression of Il1b (encoding IL-1β, a keratinocyte mitogen) 20 , was ~10-fold higher in Gli2 tg skin compared to Gli2 tg ; Krt17 −/− skin ( Table 1) . Immunostaining showed that IL-1β epitopes were strongly expressed in the skin epithelium (Fig. 2g) . Expression of Spp1 (encoding osteopontin), which acts to bias immune responses toward Th1 (ref. 21) , was reduced ~15-fold, and expression of Il6 (encoding IL-6), which is associated with the acute phase response and is upregulated in human BCC 22 , was reduced ~17-fold in Gli2 tg ; Krt17 −/− skin ( Table 1) . The matrix metalloproteases encoded by Mmp3, Mmp9 and Mmp13, whose expression is enhanced in BCC 23 , were downregulated in Gli2 tg ; Krt17 −/− ear tissue. The levels of classical Th2-type cytokines primarily secreted by T cells, for example, IL-4 (encoded by Il4) and IL-10 (encoded by Il10), were modestly altered, whereas the expression of Ccl24 and Ccr4, which are expressed in skin keratinocytes 24 , was ~9-and ~3-fold higher, respectively, in Gli2 tg ; Krt17 −/− ear tissue ( Table 1 ). The expression of many of the genes encoding these cytokines and chemokines was already altered by P40. Il1b (encoding IL-1β) and Cxcl5 expression were enhanced in the presence of Krt17, whereas expression of the Th2 markers Il20 (encoding IL-20) and Il4 (encoding IL-4) were enhanced in its absence ( Table 1) . Thus, the immunomodulatory influence of Krt17 was manifested at an early stage in this model.
Topical application of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) 25 to ear skin induces acute inflammation and epidermal proliferation (Fig. 3a,b) , providing a tumor-free, dermatitis-like setting in which to assess the impact of Krt17 loss. The latter curtails hyperplasia-driven epidermal thickening (wild-type epidermis average thickness: 34.1 μm ± 2.3 μm in TPA-treated tissue compared to 10.4 μm ± 0.3 μm in acetone-treated tissue; Krt17 −/− epidermis average thickness: 18.7 μm ± 0.8 μm in TPA-treated tissue compared to 10.6 μm ± 0.8 μm in acetone-treated tissue; Fig. 3a,b) . Markers related to compromised skin barrier function (S100A8 (ref. 26) , thymic stromal lymphoprotein 14 and β-defensin 27 ) showed elevated mRNA levels in TPA-treated wild-type skin (Fig. 3c) . 
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Thymic stromal lymphoprotein and β-defensin were markedly attenuated in Krt17 −/− skin (Fig. 3c) , suggesting better retention of barrier function. A partial shift toward a Th2-dominated cytokine profile was also seen in TPA-treated Krt17 −/− skin, though the magnitude of the shift was less than in Gli2 tg skin. The levels of the Th1 chemokines encoded by Cxcl5, Ccl3 and Il1b (IL-1β) were reduced 2.4-, 3.0-and 1.7-fold, respectively, and the level of the Th2 cytokine encoded by Il20 (IL-20) was 7.1-fold higher in TPA-treated Krt17 −/− skin relative to control skin ( Table 2) . Thus, Krt17 status exerts a similar immunomodulatory influence in a model of acute dermatitis. Skin keratinocytes from Gli2 tg and Gli2 tg ; Krt17 −/− newborn mice were seeded in primary culture for 48 h and treated with TPA for 12 h to assess whether key changes in cytokine and/or chemokine expression are keratinocyte autonomous. Under basal conditions, Gli2 tg and Gli2 tg ; Krt17 −/− cells showed rates of proliferation similar to wild-type cells and Krt17 −/− cells. TPA induced a 2-fold enhancement in Gli2 tg keratinocyte proliferation by 12 h, whereas Gli2 tg ; Krt17 −/− cells were unchanged at this time point ( Supplementary  Fig. 4b,c) . Again, key chemokines were differentially expressed depending on Krt17 status. Levels of Cxcl11, Cxcl5, Cxcl9 and Cxcl10 mRNAs, among others, were significantly lower in TPA-treated Gli2 tg ; Krt17 −/− keratinocytes ( Fig. 3d and Supplementary Fig. 4d ). These chemokines promote keratinocyte proliferation in skin tumors and show a tight spatial correlation with Krt17 expression 28, 29 . Re-expression of Krt17 in TPA-treated Gli2 tg ; Krt17 −/− keratinocytes markedly elevated the levels of Cxcl5, Cxcl9 and Cxcl11 mRNAs relative to mock-transfected cells (Fig. 3d and Supplementary Fig. 4d) . Thus, Krt17 impacts the TPA-induced expression of select chemokines relevant to BCC pathogenesis in both adult epidermis in situ and in isolated newborn keratinocytes in culture, suggesting that the mechanism(s) involved are in part cell autonomous.
Several NF-κB target genes showed a modest but consistent reduction in their expression in Gli2 tg ; Krt17 −/− relative to Gli2 tg keratinocytes in TPA-treated cultures (Supplementary Fig. 5a ). This is consistent with the prominent role of NF-κB in skin inflammatory conditions 30 and, in particular, with its impact on Cxcl5, Cxcl9 and Cxcl11 expression [31] [32] [33] . Similar analyses of P80 whole ear skin tissue revealed no difference between the genotypes, likely reflecting the large complexity of these lesions in situ and the occurrence of secondary or compensatory changes (Supplementary Fig. 5b,c) . In addition, Krt17 has been shown to promote anagen growth during hair follicle cycling 34 and to stimulate protein synthesis during tissue repair 35 . The phenotype reported here cannot be correlated to obvious alterations in these roles, again as inferred from analyses of skin tissue sections (data not shown) or extracts ( Supplementary Fig. 5b-d) .
Krt17 is ectopically expressed in numerous settings associated with robust inflammation, including cutaneous wounds, various carcinomas, psoriasis and virus-induced warts 10 . High levels of Krt17 expression correlate with a poor prognosis in breast 36 and pancreatic 37 cancers; whether this phenomenon is related to altered inflammatory signatures is an issue of interest. A correlation has also been noted between Th1 hyperactivity and Krt17 expression in psoriatic plaques 19 ; plaque resolution coincides with a shift to a Th2 response and loss of Krt17 expression. We posit that the presence of Krt17 in epidermis (and related epithelia) promotes hyperplasia in BCClike tumors and likely in additional tumors and inflammatory disease settings, in part through its ability to promote a specific type of inflammatory response. Normal contexts in which prominent Krt17 expression is not correlated to local inflammation (for example, in hair follicles) may benefit from an immune-privileged status 38 or reflect its regulation through post-translational modifications or interaction with other proteins 34, 35 . A role for Krt17 as an immunomodulator, whether direct or indirect, provides a new way of conceiving how SNPs affecting KRT5 influence the risk of developing BCC 2 and makes these keratins potentially attractive targets for new therapies aimed at curtailing conditions driven by or linked to chronic inflammation.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
